{"schema_version":"secwatch.filing_event.v1","accession":"0000064803-23-000024","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2023-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.931181+00:00","generated_at":"2026-06-14T10:56:42.877504+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"CVS Health reaffirms FY2023 GAAP EPS $6.90-$7.12 and Adj. EPS $8.50-$8.70","bullets":["Reaffirms full-year 2023 GAAP diluted EPS guidance range of $6.90 to $7.12.","Reaffirms Adjusted EPS guidance range of $8.50 to $8.70 and cash flow from operations of $12.5B-$13.5B.","Expects medical costs to remain in line with pricing; slightly >50% of earnings in H2 2023 with Q3 modestly higher than Q4.","Guidance unchanged from prior announcement; no new financial results reported."],"urls":{"canonical":"https://secwatch.observer/filing/0000064803-23-000024","json":"https://secwatch.observer/filing/0000064803-23-000024.json","markdown":"https://secwatch.observer/filing/0000064803-23-000024.md","text":"https://secwatch.observer/filing/0000064803-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000024/0000064803-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000024/cvs-20230531.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T10:56:42.877504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}